%0 Journal Article
%T Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
%A I. Aksentijevich
%A L. Marinov
%A M. Boyadzhiev
%A S. Hambleton
%A V. Boyadzhiev
%A V. Iotova
%J Archive of "Pediatric Rheumatology Online Journal".
%D 2019
%R 10.1186/s12969-019-0322-9
%X The patient: a. When he is 2£¿years 10£¿months old; b. When he is 5£¿years old, just before the start of baricitinib; c. After 7£¿months of treatment with baricitini
%K Autoinflammation
%K CANDLE syndrome
%K Immunoproteasome
%K JAK inhibitors
%K Nephrolithiasis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498627/